Roche boosts NC factory investment to $2B; Rentschler CEO steps downnews2026-01-22T15:39:09+00:00January 22nd, 2026|Endpoints News|
Another biopharma tried buying Amicus before BioMarin’s $4.8B dealnews2026-01-22T15:16:22+00:00January 22nd, 2026|Endpoints News|
Bristol Myers signs deal with Janux on T cell engager for $50M upfrontnews2026-01-22T15:15:21+00:00January 22nd, 2026|Endpoints News|
Erasca, Corvus, BioAge target $500M+ offeringsnews2026-01-22T14:43:32+00:00January 22nd, 2026|Endpoints News|
#JPM26: Hua Medicine plots diabetes drug expansion in China and beyondnews2026-01-22T12:00:28+00:00January 22nd, 2026|Endpoints News|
BioMarin vets spearhead new biotech with $82M for rare disease drugsnews2026-01-22T12:00:19+00:00January 22nd, 2026|Endpoints News|
The status of EU drug price talks depends on who you asknews2026-01-21T20:33:36+00:00January 21st, 2026|Endpoints News|
J&J praises new FDA guidance to speed development of multiple myeloma drugsnews2026-01-21T18:35:12+00:00January 21st, 2026|Endpoints News|
Johnson & Johnson brushes off MFN impact, sees strong growth for 2026news2026-01-21T16:43:28+00:00January 21st, 2026|Endpoints News|
Tanabe pill delays blood disorder; enGene adds up to $100M from loansnews2026-01-21T16:25:30+00:00January 21st, 2026|Endpoints News|
